Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO-B, stock code 06990) released a monthly return for the period ended 28 February 2026. The total authorized share capital remained at RMB 233.19 million, comprising three categories of ordinary shares: 162.77 million H shares (listed on the Exchange), 65.77 million domestic shares, and 4.64 million unlisted foreign shares. There was no change to the number of authorized or issued shares compared to the preceding month.

The minimum prescribed public float requirement for the H shares at the time of listing is 22.09%. During February 2026, there were no share repurchases, convertible securities, or additional issuance of shares. All relevant listing rules and legal requirements were confirmed to be complied with, and the total number of issued shares in each class remained the same as at the close of the previous month.